Development of a Fluorescent Microfluidic Device Based on Antibody Microarray Read-Out for Therapeutic Drug Monitoring of Acenocoumarol

The development of a proof-of-concept point-of-care (PoC) device for the determination of oral anticoagulants determination is presented. Acenocoumarol (ACL) is prescribed to prevent certain cardiovascular diseases related to the prevention of deep vein thrombosis, pulmonary embolism, myocardial inf...

Descripción completa

Detalles Bibliográficos
Autores principales: Salvador, J.-Pablo, Brettschneider, Thomas, Dorrer, Christian, Marco, M.-Pilar
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Bioengineering and Biotechnology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9002261/
https://www.ncbi.nlm.nih.gov/pubmed/35425765
http://dx.doi.org/10.3389/fbioe.2022.848501

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9002261/
https://www.ncbi.nlm.nih.gov/pubmed/35425765
http://dx.doi.org/10.3389/fbioe.2022.848501

Ejemplares similares